Co-Diagnostics Inc
For the period ended Dec 31, 2023. Filed Mar 14, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 14, 2024
CODX$0.32+24.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Financial Statements and Supplementary Data
DECEMBER 31, 2023 AND 2022
Table of Contents
| Reports of Independent Registered Public Accounting Firms (PCAOB ID No. 270 and ID No. 457) | 34 |
|---|---|
| Consolidated Balance Sheets | 36 |
| Consolidated Statements of Operations | 37 |
| Consolidated Statement of Changes in Stockholders’ Equity | 38 |
| Consolidated Statements of Cash Flows | 39 |
| Notes to Consolidated Financial Statements | 40 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.